Considering the lessons short squeezes can offer about the inherent danger of carrying excessive leverage or short positions during periods of heightened risk and illiquidity.
Recessionary dynamics
The consensus was complacent about recession risk and is now underestimating its likely severity, argues Simon Ward, Economic Adviser.
What’s hitting the new Chancellor’s to-do list, UK growth fears and outlook for UK banks
Dan Coatsworth, Editor at Shares Magazine, talks to Laura Foll, Co-Portfolio Manager of Lowland Investment Company and Henderson Opportunities Trust about the outlook for UK banks, which are much loved by many investors.
Investing through the ups and downs of biopharma research
The biopharmaceutical industry often moves to the beat of its own drummer, creating opportunities for diversification.
Investing through the Ups and Downs of Biopharma Research
The biopharmaceutical industry often moves to the beat of its own drummer, creating opportunities for diversification.
Investing through the ups and downs of biopharma research
The biopharmaceutical industry often moves to the beat of its own drum, creating opportunities for diversification.
Decarbonisation in emerging markets: perspectives and insights from Asia
Decarbonisation efforts across Asia are hampered by a fragmented market, but recent trends are encouraging.
Research in Action: Investing through the Ups and Downs of Biopharma Research
The biopharmaceutical industry often moves to the beat of its own drummer, creating opportunities for diversification.
A Balanced Approach…
Portfolio Managers Greg Wilensky, CFA, and David Chung, CFA provide key takeaways from their discussion on navigating market uncertainty and volatility.
Decarbonisation in emerging markets: perspectives and insights from Asia
Decarbonisation efforts across Asia are hampered by a fragmented market, but recent trends are encouraging.